XCellAssay Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed
  • (Postponed)

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 3

XCellAssay General Information

Description

Developer of a wellness technology designed for measuring the levels of chemical pollutants called 'endocrine disruptors' in the surroundings. The company's low-cost technology uses engineered cell lines and miniaturized measurement methods to report on endocrine disrupting activities in your home water or blood samples, and foreign chemicals absorbed into their bodies from their home and work surroundings, enabling clients to access a low-cost, exquisitely accurate, and convenient way to measure a pan-androgenic activity in ultra-low volumes of body liquids.

Contact Information

Website
www.xcellassay.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1128 Haight Street
  • San Francisco, CA 94117
  • United States
+1 (415) 000-0000
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • 1128 Haight Street
  • San Francisco, CA 94117
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XCellAssay Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round $1.5M Postponed Product Development
5. Grant 00000 Completed Product In Beta Test
4. Grant 20-Nov-2021 Completed Startup
3. Grant 30-Sep-2018 Completed Startup
2. Accelerator/Incubator 01-Jun-2017 Completed Startup
1. Accelerator/Incubator 01-Apr-2014 Completed Startup
To view XCellAssay’s complete valuation and funding history, request access »

XCellAssay Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a wellness technology designed for measuring the levels of chemical pollutants called 'endocrine disruptors
Biotechnology
San Francisco, CA
3 As of 2023
0000

000000

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
00000 0000000000 000
Dublin, Ireland
000 As of 0000
00000
000000000 00000

0000 0

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000 00000000 000-0
Madison, IN
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XCellAssay Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LetsGetChecked Venture Capital-Backed Dublin, Ireland 000 00000 000000000 00000
Safe Home (Indiana) Corporation Madison, IN
SimpleLab Venture Capital-Backed Berkeley, CA 00 00.000 0000000000 0 00.000
Everly Health Private Equity-Backed Austin, TX 000 00000 0000000 0000 00000
WaterCheck Corporation Kerhonkson, NY
You’re viewing 5 of 5 competitors. Get the full list »

XCellAssay Executive Team (4)

Name Title Board Seat
Fred Schaufele Ph.D Co-Founder, Chief Executive Officer & Director of Scientific Operations
Mei Ling Co-Founder & Director Of Consumer IT
Irina Krylova Ph.D Co-Founder & Director of Environmental Studies
HaiGuang Zhang Ph.D Co-Founder & Director of Technology
To view XCellAssay’s complete executive team members history, request access »

XCellAssay Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XCellAssay Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Partnership For Clean Competition Corporation Minority 000 0000 000000 0
MBC BioLabs Accelerator/Incubator 000 0000 000000 0
QB3 Accelerator/Incubator 000 0000 000000 0
To view XCellAssay’s complete investors history, request access »

Ready to get started?

Request a free trial

XCellAssay FAQs

  • When was XCellAssay founded?

    XCellAssay was founded in 2013.

  • Who is the founder of XCellAssay?

    Fred Schaufele Ph.D, Mei Ling, Irina Krylova Ph.D, and HaiGuang Zhang Ph.D are the founders of XCellAssay.

  • Who is the CEO of XCellAssay?

    Fred Schaufele Ph.D is the CEO of XCellAssay.

  • Where is XCellAssay headquartered?

    XCellAssay is headquartered in San Francisco, CA.

  • What is the size of XCellAssay?

    XCellAssay has 3 total employees.

  • What industry is XCellAssay in?

    XCellAssay’s primary industry is Biotechnology.

  • Is XCellAssay a private or public company?

    XCellAssay is a Private company.

  • What is XCellAssay’s current revenue?

    The current revenue for XCellAssay is 000000.

  • Who are XCellAssay’s investors?

    Partnership For Clean Competition, MBC BioLabs, and QB3 have invested in XCellAssay.

  • Who are XCellAssay’s competitors?

    LetsGetChecked, Safe Home (Indiana), SimpleLab, Everly Health, and WaterCheck are competitors of XCellAssay.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »